Inventor · disambiguated record
Frank R. Jones
Also filed as: JONES FRANK · JONES FRANK R
39 granted patents·11 pending applications·586 citations·filing 1986–2024
98Inventor score
Top patents by PatentIndex Score
50 records- 0197US11504423B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2022·Granted Nov 22, 2022·2 cites·18 claims
- 0295US11826417B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2022·Granted Nov 28, 2023·1 cites·19 claims
- 0395US11529408B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2022·Granted Dec 20, 2022·1 cites·19 claims
- 0495US11389521B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2020·Granted Jul 19, 2022·3 cites·18 claims
- 0594US5236645AAddition of additives to polymeric materialsBASF CORP·Filed 1992·Granted Aug 17, 1993·80 cites·23 claims
- 0693US10695417B2Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoproteinETUBICS CORP·Filed 2016·Granted Jun 30, 2020·9 cites·25 claims
- 0793US8298549B2Sequential administration of a replication defective adenovirus vector in vaccination protocolsBALINT JOSEPH P·Filed 2010·Granted Oct 30, 2012·21 cites·26 claims
- 0893US5834089AAdditive-containing synthetic filaments, and yarns and carpets including such filamentsBASF CORP·Filed 1997·Granted Nov 10, 1998·55 cites·39 claims
- 0992US12370250B2Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2024·Granted Jul 29, 2025·0 cites·19 claims
- 1092US11376316B2Breast cancer vaccines and methods of use thereofETUBICS CORP·Filed 2016·Granted Jul 5, 2022·3 cites·14 claims
- 1192US11369673B2HPV vaccines and methods of use thereofETUBICS CORP·Filed 2016·Granted Jun 28, 2022·3 cites·16 claims
- 1291US11104916B2Compositions and methods for alphavirus vaccinationETUBICS CORP·Filed 2017·Granted Aug 31, 2021·6 cites·17 claims
- 1391US10563224B2Replication defective adenovirus vector in vaccinationETUBICS CORP·Filed 2017·Granted Feb 18, 2020·5 cites·18 claims
- 1490US11344613B2Sequential administration of a replication defective adenovirus vector in vaccination protocolsETUBICS CORP·Filed 2012·Granted May 31, 2022·3 cites·16 claims
- 1588US9605276B2Replication defective adenovirus vector in vaccinationJONES FRANK R·Filed 2013·Granted Mar 28, 2017·12 cites·22 claims
- 1688US2023364218A1Methods and compositions for producing an adenovirus vector for use with multiple vaccinationsETUBICS CORP·Filed 2023·Application pending·0 cites
- 1787US11304998B2Combination immunotherapies comprising IL-15 superagonistsETUBICS CORP·Filed 2021·Granted Apr 19, 2022·1 cites·9 claims
- 1883US11149087B2Methods and compositions for combination immunotherapyETUBICS CORP·Filed 2016·Granted Oct 19, 2021·2 cites·25 claims
- 1982US5037649AMethod for treatment of HIV-infected patientsIMRE CORP·Filed 1989·Granted Aug 6, 1991·35 cites·41 claims
- 2081US11116827B2Compositions and methods for tumor vaccination and immunotherapy involving HER antigensETUBICS CORP·Filed 2018·Granted Sep 14, 2021·1 cites·14 claims
- 2181US11020467B2Combination immunotherapies comprising IL-15 superagonistsETUBICS CORP·Filed 2018·Granted Jun 1, 2021·1 cites·10 claims
- 2279US10835596B2Compositions and methods for flavivirus vaccinationETUBICS CORP·Filed 2017·Granted Nov 17, 2020·2 cites·16 claims
- 2377US12487241B2Rapid verification of virus particle production for a personalized vaccineNANTCELL INC·Filed 2022·Granted Dec 2, 2025·0 cites·13 claims
- 2476US5833893AMethods of making different additive-containing filamentsBASF CORP·Filed 1997·Granted Nov 10, 1998·16 cites·17 claims
- 2576US5122112AAntigen-specific removal of circulating immune complexesIMRE CORP·Filed 1990·Granted Jun 16, 1992·42 cites·10 claims
- 2674US5800746AMethods of making pigmented synthetic filamentsBASF CORP·Filed 1997·Granted Sep 1, 1998·17 cites·39 claims
- 2772US6410614B1Incorporating titanium dioxide in polymeric materialsBASF CORPOTATION·Filed 2000·Granted Jun 25, 2002·15 cites·30 claims
- 2871US6416859B1Methods of making pigmented filamentsBASF CORP·Filed 2000·Granted Jul 9, 2002·8 cites·27 claims
- 2971US4801449AMethod for treatment of Kaposi's sarcomaIMRE CORP·Filed 1986·Granted Jan 31, 1989·23 cites·10 claims
- 3069US2023406804A1Protein kinase inhibitorsXAVIER UNIV OF LOUISIANA·Filed 2023·Application pending·0 cites
- 3167US11573230B2Rapid verification of virus particle production for a personalized vaccineNANTCELL INC·Filed 2019·Granted Feb 7, 2023·0 cites·12 claims
- 3267US2021138056A1Neoepitope vaccine compositions and methods of use thereofETUBICS CORP·Filed 2021·Application pending·0 cites
- 3364US11352642B2Methods and compositions for combination immunotherapyETUBICS CORP·Filed 2016·Granted Jun 7, 2022·1 cites·14 claims
- 3462US5955516AMethods of making dispersible additives for polymeric materialsBASF CORP·Filed 1997·Granted Sep 21, 1999·10 cites·11 claims
- 3561US5869551ADispersible additive systems for polymeric materialsBASF CORP·Filed 1997·Granted Feb 9, 1999·11 cites·6 claims
- 3661US5782792AMethod for treatment of rheumatoid arthritisCYPRESS BIOSCIENCE INC·Filed 1994·Granted Jul 21, 1998·95 cites·13 claims
- 3760US6232371B1Dispersible additive systems for polymeric materials, and methods of making and incorporating the same in such polymeric materialsBASF CORP·Filed 1998·Granted May 15, 2001·16 cites·37 claims
- 3858US2020282032A1Neoepitope vaccine compositions and methods of use thereofETUBICS CORP·Filed 2017·Application pending·0 cites
- 3957US2021355060A1Protein kinase inhibitorsXAVIER UNIV OF LOUISIANA·Filed 2019·Application pending·0 cites
- 4056US5889089AAdditive-containing polymeric compositions and methods of making the sameBASF CORP·Filed 1997·Granted Mar 30, 1999·10 cites·20 claims
- 4152US2021046177A1Compositions and methods for combination cancer vaccine and immunologic adjuvant therapyNANTCELL INC·Filed 2019·Application pending·0 cites
- 4247US7019050B2Alternate dispersants for spray-dried concentrate componentsBASF CORP·Filed 2003·Granted Mar 28, 2006·0 cites·21 claims
- 4344US5733254AMethod for treating patients suffering from immune thrombocytopenic purpuraCYPRESS BIOSCIENCE INC·Filed 1995·Granted Mar 31, 1998·44 cites·25 claims
- 4444US2019022209A1Methods and compositions for influenza vaccinationETUBICS CORP·Filed 2017·Application pending·0 cites
- 4543US2019125852A1Compositions and methods for tumor vaccination using prostate cancer-associated antigensETUBICS CORP·Filed 2017·Application pending·0 cites
- 4643US2019134195A1Compositions and methods for the treatment of human papillomavirus (hpv)-associated diseasesETUBICS CORP·Filed 2017·Application pending·0 cites
- 4742US2019134174A1Compositions and methods for tumor vaccination and immunotherapy involving her2/neuETUBICS CORP·Filed 2017·Application pending·0 cites
- 4841US5973032ADispersible additive systems for polymeric materialsBASF CORP·Filed 1997·Granted Oct 26, 1999·3 cites·8 claims
- 4940US2019030151A1Methods and compositions for t-cell immunotherapyETUBICS CORP·Filed 2017·Application pending·0 cites
- 5037US4865841AMethods and compositions for transient elimination of humoral immune antibodiesIMRE CORP·Filed 1987·Granted Sep 12, 1989·29 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →